COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
After months of controversy, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have given a green light to the COVID-19 booster programme in the US.
The FDA’s decision to extend the emergency use authorisation (EUA) for Pfizer’s Comirnaty vaccine comes just days after it convened a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC).
COVID-19 Pfizer/BioNTech booster approved by FDA and CDC – PMLiVE
